ICAD
Icad Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
icad is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. icad offers a comprehensive range of high-performance, upgradeable cad solutions for mammography and advanced image analysis and workflow solutions for magnetic resonance imaging, for breast and prostate cancers and computed tomography for colorectal cancer. icad’s xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. the xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. for more information, call 877-icadnow, or visit www.icadmed.com.
Market Cap: 51.7 Million
Primary Exchange: NASDAQ
Website: icadmed.com
Shares Outstanding: 26.4 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.6232484256444557
Sector: Manufacturing
Industry: Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Ethical Flags
Longest drawdown: 1670 trading days
From: 2014-01-16 To: 2020-03-03
Lowest Point:
SVRA and HEB among premarket losers
via: SeekingAlpha at 2019-06-13 05:09:48:000
Savara (NASDAQ: SVRA ) -76% as Molgradex flunks late-stage aPAP study. More news on: Savara Inc., Hemispherx Biopharma, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more … read more...
iCAD prices stock offering
via: SeekingAlpha at 2019-06-13 03:15:02:000
iCAD (NASDAQ: ICAD ) has priced 1.63M common shares at $5.50/share, for gross proceeds of ~$9M or net proceeds of ~$8.3M. More news on: iCAD, Inc., Healthcare stocks news, Read more … read more...
iCAD down ~7% on proposed secondary offering
via: SeekingAlpha at 2019-06-12 12:47:10:000
iCAD commenced an underwritten public offering, and underwriter have an option to purchase an additional of up to 15% of shares sold in the offering. More news on: iCAD, Inc., Healthcare stocks news, Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|